BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells

FEBS Letters

Volumn 535, Issue 1-3, 2003, Pages 17-22

  Traina, Fabíola ^a   Carvalheira, José Barreto C ^a   Saad, Mario J A ^a   Costa, Fernando F ^a   Saad, Sara T O ^a   Superti Furga, Giulio ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE

Author keywords

BCR ABL; Chronic myeloid leukemia; Imatinib; IRS 1; K562 cells

Indexed keywords

BCR ABL PROTEIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMATINIB; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 0037472637     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03845-0     Document Type: Conference Paper

References (31)

1. Cortez D., Kadlec L., Pendergast A.M. Mol. Cell. Biol. 15:1995;5531-5541.
2. Deininger M.W., Goldman J.M., Melo J.V. Blood. 96:2000;3343-3356.
3. Druker B.J., Tamura S., Buchdunger E., Ohno S., Segal G.M., Fanning S., Zimmermann J., Lydon N.B. Nat. Med. 2:1996;561-566.
4. Gambacorti-Passerini C., et al. Blood Cells Mol. Dis. 23:1997;380-394.
5. Deininger M.W., Goldman J.M., Lydon N., Melo J.V. Blood. 90:1997;3691-3698.
6. Druker B.J., Lydon N.B. J. Clin. Invest. 105:2000;3-7.
7. Wang L.M., Myers M.G. Jr., Sun X.J., Aaronson S.A., White M., Pierce J.H. Science. 261:1993;1591-1594.
8. Folli F., Saad M.J., Backer J.M., Kahn C.R. J. Biol. Chem. 267:1992;22171-22177.
9. Kelly K.L., Ruderman N.B. J. Biol. Chem. 268:1993;4391-4398.
10. Skolnik E.Y., Batzer A., Li N., Lee C.H., Lowenstein E., Mohammadi M., Margolis B., Schlessinger J. Science. 260:1993;1953-1955.
11. Sun X.J., et al. Nature. 352:1991;73-77.
12. Lee C.H., et al. Proc. Natl. Acad. Sci. USA. 90:1993;11713-11717.
13. Bradford M.M. Anal. Biochem. 72:1976;248-254.
14. Saad M.J., Folli F., Kahn C.R. Endocrinology. 136:1995;1579-1588.
15. Sun X.J., et al. Nature. 377:1995;173-177.
16. Coughlin S.R., Escobedo J.A., Williams L.T. Science. 243:1989;1191-1194.
17. Wages D.S., Keefer J., Rall T.B., Weber M.J. J. Virol. 66:1992;1866-1874.
18. Sattler M., et al. Oncogene. 12:1996;839-846.
19. Pawson T. Nature. 373:1995;573-580.
20. Buchdunger E., Cioffi C.L., Law N., Stover D., Ohno-Jones S., Druker B.J., Lydon N.B. J. Pharmacol. Exp. Ther. 295:2000;139-145.
21. Ricort J.M., Tanti J.F., Van Obberghen E., Le Marchand-Brustel Y. J. Biol. Chem. 272:1997;19814-19818.
22. Staubs P.A., Nelson J.G., Reichart D.R., Olefsky J.M. J. Biol. Chem. 273:1998;25139-25147.
23. Serve H., Hsu Y.C., Besmer P. J. Biol. Chem. 269:1994;6026-6030.
24. Serve H., Yee N.S., Stella G., Sepp-Lorenzino L., Tan J.C., Besmer P. EMBO J. 14:1995;473-483.
25. Pendergast A.M., et al. Cell. 75:1993;175-185.
26. Puil L., Liu J., Gish G., Mbamalu G., Bowtell D., Pelicci P.G., Arlinghaus R., Pawson T. EMBO J. 13:1994;764-773.
27. Bartram C.R., et al. Nature. 306:1983;277-280.
28. Pelicci G., et al. Oncogene. 11:1995;899-907.
29. Sattler M., et al. Cancer Cell. 1:2002;479-492.
30. Dan S., Naito M., Tsuruo T. Cell Death Differ. 5:1998;710-715.
31. Yu C., Krystal G., Varticovksi L., McKinstry R., Rahmani M., Dent P., Grant S. Cancer Res. 62:2002;188-199.